Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScopeⓇ-Global Registry for Emerging Fungal Infections
Language English Country England, Great Britain Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
32798532
DOI
10.1016/j.jinf.2020.08.015
PII: S0163-4453(20)30549-1
Knihovny.cz E-resources
- Keywords
- Invasive fungal infections, Mold, Rare, Registry, Yeast,
- MeSH
- Antifungal Agents therapeutic use MeSH
- Invasive Fungal Infections * drug therapy epidemiology MeSH
- Humans MeSH
- Mycoses * drug therapy epidemiology MeSH
- Registries MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Antifungal Agents MeSH
OBJECTIVES: Emerging invasive fungal infections (IFI) have become a notable challenge. Apart from the more frequently described fusariosis, lomentosporiosis, mucormycosis, scedosporiosis, and certain dematiaceae or yeasts, little is known about extremely rare IFI. METHODS: Extremely rare IFI collected in the FungiScopeⓇ registry were grouped as Dematiaceae, Hypocreales, Saccharomycetales, Eurotiales, Dermatomycetes, Agaricales, and Mucorales. RESULTS: Between 2003 and June 2019, 186 extremely rare IFI were documented in FungiScopeⓇ. Dematiaceae (35.5%), Hypocreales (23.1%), Mucorales (11.8%), and Saccharomycetales (11.3%) caused most IFI. Most patients had an underlying malignancy (38.7%) with acute leukemia accounting for 50% of cancers. Dissemination was observed in 26.9% of the patients. Complete or partial clinical response rate was 68.3%, being highest in Eurotiales (82.4%) and in Agaricales (80.0%). Overall mortality rate was 29.3%, ranging from 11.8% in Eurotiales to 50.0% in Mucorales. CONCLUSIONS: Physicians are confronted with a complex variety of fungal pathogens, for which treatment recommendations are lacking and successful outcome might be incidental. Through an international consortium of physicians and scientists, these cases of extremely rare IFI can be collected to further investigate their epidemiology and eventually identify effective treatment regimens.
Clinical Microbiology and Parasitology Department University Hospital La Paz Madrid Spain
Department of Microbiology Government Medical College and Hospital Chandigarh India
Department of Microbiology School of Medicine Universidad Autonóma de Nuevo León Nuevo León Mexico
Institute of Hygiene and Medical Microbiology Medical University of Innsbruck Innsbruck Austria
Laboratory of Antimicrobial Chemotherapy Ion Ionescu de la Brad University Iași Romania
Mechnikov North Western State Medical University St Petersburg Russian Federation
Parasitology Mycology Unit University Hospital Center Fort de France Martinique French West Indies
References provided by Crossref.org